2. Academic Validation
  3. Cytotoxicity of activator expression in CRISPR-based transcriptional activation systems

Cytotoxicity of activator expression in CRISPR-based transcriptional activation systems

  • Nat Commun. 2025 Aug 29;16(1):8071. doi: 10.1038/s41467-025-63570-4.
Ziyan Liang 1,  Aakaanksha Maddineni 1,  Jesus A Ortega 1,  Christine B Magdongon 1,  Shreya Jambardi 1,  Subrata Roy 1,  Josh Tycko 2,  Ajinkya Patil 1,  Mark Manzano 3,  Elizabeth T Bartom 4,  Eva Gottwein 5
Affiliations

Affiliations

  • 1 Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
  • 2 Department of Neurobiology, Harvard University, Boston, MA, USA.
  • 3 Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • 4 Departments of Biochemistry and Molecular Genetics and Preventive Medicine (Biostatistics and Informatics), Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
  • 5 Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA. e-gottwein@northwestern.edu.
PMID: 40877321 DOI: 10.1038/s41467-025-63570-4
Abstract

CRISPR-based transcriptional activation (CRISPRa) has extensive research and clinical potential. Here, we show that commonly used CRISPRa systems can exhibit pronounced cytotoxicity. We demonstrate the toxicity of CRISPRa vectors expressing the activation domains (ADs) of the transcription factors p65 and HSF1, components of the synergistic activation mediator (SAM) CRISPRa system. Based on our findings for the SAM system, we extended our studies to additional ADs and acetyltransferase core domains. We show that the expression of potent transcriptional activators in lentiviral producer cells can lead to low lentiviral titers, while their expression in the transduced target cells leads to cell death. Using inducible lentiviral vectors, we could not identify an activator expression window for effective SAM-based CRISPRa without measurable toxicity. The toxicity of current SAM-based CRISPRa systems hinders their wide adoption in biomedical research and introduces selection pressures that may confound genetic screens. Our results suggest that the further development of CRISPRa technology should consider both the efficiency of gene activation and activator toxicity.

Figures
Products